Quantcast

Fosamax litigation ready for next step in bellwether cases (access required)

By: Correy Stephenson
Staff writer
Published: December 4, 2012

Tags: , , , , ,

Six years after the first Fosamax lawsuit was filed, litigation over the osteoporosis drug is about to start a new chapter. The suits against Merck, the drug’s manufacturer, fall into two categories: plaintiffs alleging they suffer from osteonecrosis, or jaw damage, and those claiming they suffered a non-traumatic femur fracture as a result of taking the drug.
© Copyright 2013 Lawyers USA. All Rights Reserved.


Comments

You must be logged in to post comments.

Sign-up for alerts

FEATURED PODCAST


Lawyers USA presents Lawyers in Practice

This is the first edition of Lawyers USA's Lawyers in Practice, where we discuss the hot issues facing practicing attorneys and law firms.

In this edition, we discuss how to prevent legal malpractice claims with better communication, with Jim Calloway, director of the Oklahoma Bar Association's Management Assistance Program, and Dan Pinnington, vice-president of Claims Prevention and Stakeholder Relations at LawPRO, a professional liability carrier based in Toronto, Canada.

Visit the Legal Malpractice Monitor to listen to the podcast.

Click here to download the podcast.